KIT and melanoma: Moreover, as KIT mutations have been implicated in small-cell lung carcinoma, melanoma, colorectal cancer and more than 80% of gastrointestinal stromal tumours39, autologous transplant of engineered HSPCs could theoretically improve the therapeutic index of KIT-directed therapies also for non-haematological malignancies.